Drug eruption is the most common clinical presentation in patients with HIV/AIDS. The systemic clinical and risk factors associated with drug eruption remain unknown. A retrospective analysis in HIV/AIDS patients with drug eruption was carried out with demographic data, epidemiological data, clinical characteristics, laboratory data and follow-up data. The risk factors correlated with prognosis...

Background: Skin eruption is a disease that it is because of skin necrosis and adolescence and youth depression. The some species of Staphylococcuss are agent of this disease. There isn’t effective drug for curing of this disease. Many of medicinal plants (e.x. Stachys inflata Benth.) have anti- bacterial compounds and they can be used as a drug to cure skin eruption disease. Objective: This r...

BACKGROUND The diagnosis of fixed 'drug' eruption is not difficult for dermatologists, but it is difficult to identify the causative agent when the patient denies ingestion of any drugs. There have been some reported cases of fixed 'food' eruption. CASE SUMMARY A 71-year-old woman experienced repeated erythema and tense bulla with a burning sensation and pruritus on the right ankle. The erupt...

INTRODUCTION Fluconazole is a widely used antifungal agent with a possible side effect of fixed drug eruption. However, this adverse drug effect is absent from the reported list of possible side effects of fluconazole. We are presenting a rare case in our report. CASE PRESENTATION A 25-year-old Iranian woman developed fixed drug eruptions on different sites of her body after taking five doses...

3. Thirion L, Nikkels AF, Piérard GE. Etoricoxib-induced erythemamultiforme-like eruption. Dermatology. 2008;216:227--8. 4. Kreft B, Wohlrab J, Bramsiepe I, Eismann R, Winkler M, Marsch WC. Etoricoxib-induced toxic epidermal necrolysis: successful treatment with infliximab. J Dermatol. 2010;37:904--6. 5. Augustine M, Sharma P, Stephen J, Jayaseelan E. Fixed drug eruption and generalised erythem...

3. Thirion L, Nikkels AF, Piérard GE. Etoricoxib-induced erythemamultiforme-like eruption. Dermatology. 2008;216:227--8. 4. Kreft B, Wohlrab J, Bramsiepe I, Eismann R, Winkler M, Marsch WC. Etoricoxib-induced toxic epidermal necrolysis: successful treatment with infliximab. J Dermatol. 2010;37:904--6. 5. Augustine M, Sharma P, Stephen J, Jayaseelan E. Fixed drug eruption and generalised erythem...

A 65-year-old man had relapsed follicular lymphoma. When he suffered a fifth relapse, he received a regimen containing bendamustine and rituximab (BR). Four weeks later, he presented with systemic erythema, swelling and bullous lesions of lips, the oral cavity, andnasal mucosa and eye pain. He could not open his mouth and had severe pain. Steven–Johnson syndrome/toxic epidermal necrolysis was d...

Background: Previous studies indicated that eosinophils infi ltrate the skin during drug eruptions and that counts may become elevated in circulation. However, little is known about the role of eosinophils in the prognosis of patients with drug eruption. Objective: This study aims to investigate the correlation between circulating eosinophil counts and the prognosis of patients with drug erupti...

The principles behind the primary localization of lesions in fixed drug eruption are still unknown. Studies investigating the predilection areas indicated drug-related, trauma-related or inflammation-related specific site involvement in fixed drug eruption. This study presents new findings of primary site involvement on the maximal points of Head's zones. In the 3 cases reported here, fixed dru...